Study on the onset time of trotagliptin’s hypoglycemic effect

An in-depthPhase 2 clinical trial pointed out that compared with the control group, patients treated with Trelagliptin showed a more significant decrease in glycated hemoglobin A1c (HbA1c) levels. It is worth noting that research data shows that the hypoglycemic effect of trolagliptin is positively correlated with its dose, which means that as the dose increases, its hypoglycemic effect becomes more obvious. At the same time, the study also highlighted the safety and patient tolerability of trolagliptin during treatment, indicating that it is a trustworthy treatment.

Another phase 3 double-blind randomized controlled trial lasting 24 weeks further confirmed the efficacy of trolagliptin. In this trial, the effects of weekly 100 mg trolagliptin were compared with daily doses of the DPP-4 inhibitor alogliptin, and the results showed that trolagliptin was not inferior to alogliptin. At the same time, this study once again confirmed the safety of trolagliptin in treatment and its good tolerance by patients.

In order to more comprehensively evaluate the long-term effects of trolagliptin, a 52-week phase 3 open-label study was also conducted. This study examined the effects of trolagliptin alone or in combination with other oral antidiabetic drugs. The results of the study show that during long-term use, trotagliptin has demonstrated sustained hypoglycemic effects, whether as monotherapy or combination therapy, and its safety has also been verified over the long term.

In summary, trotagliptin, as an innovative, long-actingDPP-4 inhibitor, has shown significant effects in hypoglycemic treatment when administered once a week. Although current research has proven its efficacy and safety, more refined research is still needed to provide a definite answer as to how long it will take for the hypoglycemic effect of trolagliptin to be evident. Before considering the use of troagliptin, patients should consult a professional physician to develop the most appropriate treatment plan for their situation.